In addition, we found the UC-MSCs induced CD1c+DCs in the lupus patients exerted tolerogenic properties by decreasing expression of CD80, CD83, CD86 and HLA-DR, decreasing production of TNFα and keeping production of IL-10. Here, CD83 is linked to systemic lupus erythematosus.